ELDISINE subst sèche 5 mg flac
7680428630251
CH-42863
L01CA03
07.16.1.
Reimbursement limitations:
ELDISINE
Remboursé dans le cadre d'un traitement combiné chez les patients atteints de leucémie aiguë lymphoblastique …
1 / 3
google
Details
- Product number
- 4286302
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: vindesini sulfas 5 mg, mannitolum, acidum sulfuricum q.s. ad pH, natrii hydroxidum q.s. ad pH pro vitro corresp. natrium max 0.1 mg.
Articles (1)
Eldisine, Pulver zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 154.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 42863
- Drug name
- Eldisine, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- L01CA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/03/1982
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ELDISINE subst sèche 5 mg flac
- Description (DE)
- ELDISINE Trockensub 5 mg Durchstf
- Market launch
- 10/06/1997
- Market withdrawal
- 08/08/2025
- Narcotic (BTM)
- No